Skip to main content
Genomics & Informatics logoLink to Genomics & Informatics
. 2012 Jun 30;10(2):128–132. doi: 10.5808/GI.2012.10.2.128

Characteristics in Molecular Vibrational Frequency Patterns between Agonists and Antagonists of Histamine Receptors

S June Oh 1,
PMCID: PMC3480680  PMID: 23105941

Abstract

To learn the differences between the structure-activity relationship and molecular vibration-activity relationship in the ligand-receptor interaction of the histamine receptor, 47 ligands of the histamine receptor were analyzed by structural similarity and molecular vibrational frequency patterns. The radial tree that was produced by clustering analysis of molecular vibrational frequency patterns shows its potential for the functional classification of histamine receptor ligands.

Keywords: corralled intensity of molecular vibrational frequency, G protein-coupled receptors, histamine receptors, molecular vibration-activity relationship

Introduction

G protein-coupled receptors (GPCRs) are regarded to take up more than one-fourth of marketed human medicines [1, 2]. Drugs targeting GPCRs account for the majority of the best-selling drugs and about 40% of all prescription pharmaceuticals in the marketplace [3].

Histamine receptors belong to one family of rhodopsin-like class A GPCRs, and four subtypes are named in chronological order as H1, H2, H3, and H4. Histamine exerts its effects through the activation of these four histamine receptors. Each type of histamine receptor reacts to subtype-specific ligands into an active or inactive form.

GPCRs are integral membrane proteins that consist of 7 transmembrane segments connected by 3 intracellular and 3 extracellular loops of variable length. The crystal structures of GPCRs with their binding ligands have revealed the features of the ligand binding pockets and extracellular loops [4-6]. A ligand of GPCR activates the receptor by changing the receptor structure to the active form.

The biogenic amine histamine [2-(1H-imidazol-5-yl) ethanamine] (Fig. 1) is produced by decarboxylation of L-histidine and acts as a chemical mediator and neurotransmitter in central and peripheral tissues. It acts as an important pharmacological modulator involved in the processes of allergy, inflammation, neurophysiology, and cancer [7-10].

Fig. 1.

Fig. 1

The chemical structure of histidine.

The molecular understanding of ligand-receptor interactions of GPCR remains unclear and is still the subject of investigations. There are several theories explaining the ligand-receptor interaction mechanism, such as shape theory, binding theory, and vibration theory [11, 12]. The structures of histamine receptor ligands are so variable that we can not easily classify the pharmacological function of the ligand. To find any other characteristic in the molecular patterns between agonists and antagonists of histamine receptors, a computational approach to molecular vibration was carried out in an attempt to find a bit of the molecular interaction mechanisms.

Methods

Dataset

The simplified molecular-input line-entry system (SMILES) and 3-dimensional structure data format (SDF) files of the dataset were downloaded from the PubChem Compound Database in National Center for Biotechnology Information (NCBI) and used in the further analyses. All 47 ligand molecules in the dataset, comprising 9 histamine agonists and 38 histamine antagonists, are shown in Table 1.

Table 1.

List of agonists and antagonists used in the present study

graphic file with name gni-10-128-i001.jpg

Structure comparison of histamine receptor ligands

The molecular similarities between histamine and other 46 chemicals were calculated from SMILES of the chemicals. The structural similarity was calculated and represented as the Tanimoto distance of each molecule from histamine. The Tanimoto coefficient for pairwise comparison of molecules is the most widely used measure of molecular structural similarity. This coefficient is defined as Tc = Nab/(Na + Nb - Nab), with Nab being the number of common bits, Na the unique bits in molecule a, and Nb the unique bits in molecule b, using a molecular fingerprint [13]. In this study, the molecular similarity was calculated as the Tanimoto coefficient using the 38-bit set.

Geometry optimization and calculation of molecular vibrational frequency

In order to calculate molecular vibrational frequency, the structure of a chemical must first be geometrically optimized. Since each provided theoretical 3-D conformer SDF is not at an energy minimum and may not represent the lowest energetic form in a vacuum, solvent, or a binding pocket, each SDF file of a ligand molecule underwent conversion to a single low-energy conformation using the general atomic and molecular electronic structure system (GAMESS) program package [14]. Restricted Hartree-Fock (RHF) calculations using Becke's exchange and Lee-Yang-Parr's correlation functionals (BLYP) density functional theory (DFT) method with 6-31G basis set were performed to optimize the geometries of the molecules. Each result was taken as the representative conformation of the molecule, although the calculation of molecular vibrational frequency has some dependence on conformation. Each geometry optimization result was subjected to the calculation step for the vibrational frequency with RUNTYP of HESSIAN in the GAMESS program.

Hierarchical clustering of the corralled intensity of molecular vibrational frequency (CIMVF)

For the simplified molecular comparison, the calculated vibrational frequencies of a molecule were then sorted in increasing order and taken into the corrals, the step size of which was 5. The intensities of each frequency in the same corral were summed up as the representative of the corral in the frequency range of 0-5,000 cm-1. As a final outcome, this potential molecular descriptor of each molecule was displayed in a 1-dimensional vector containing 1,000 elements. Finally, the similarity matrix, comprising the descriptors of 47 ligands of histamine receptor, was then subjected to hierarchical clustering in the agglomerative manner. In this study, the similarity matrix was finally clustered to make an unrooted tree of 47 vertices. The calculations of CIMVF were performed by in-house scripts, written in Python.

Results and Discussion

The Tanimoto coefficients between histamine and other ligand molecules are shown in Table 2. Typically, a Tanimoto coefficient > 0.85 is considered highly similar, and a coefficient > 0.75 is considered similar for the purpose of clustering molecules that may have similar biological activity profiles [15]. The highest Tanimoto coefficient among agonists was 0.45 (imetit), and this is not high enough to be considered a molecule that has potential agonist efficacy. Moreover, the lowest value of Tanimoto coefficient among agonists was 0.08 (dimaprit and SKF91488) and is also a lower value as an antagonist. It seems that there is no related pattern between Tanimoto coefficients and the functional types of molecules in the case of histamine receptor agonists or antagonists.

Table 2.

The molecular similarity between histamine and each ligand molecule in Tanimoto coefficient

graphic file with name gni-10-128-i002.jpg

The Tanimoto coefficients between histamine and other ligand molecules are listed in descending order.

To search for a novel characteristic for the classification of histamine receptor ligands, a kind of molecular calculation using agglomerative hierarchical clustering was adopted in this work. The result of the hierarchical clustering of the similarity matrix from CIMVF is shown in Fig. 2. As shown in the figure, eight agonists were located nearby (the part in the dotted circle), except impromidine, and all antagonists were clustered close to each other in the radial tree. We can tell the regional difference between agonists and antagonists in the tree and also find that the information from the molecular vibrational frequency may play a role in the classification of agonists/antagonists for histamine receptor as a possible molecular descriptor. For these methods, clustering with CIMVF shows the more proper result in the case of histamine receptor ligands. With a more concentrated study on the relationship between the molecular vibrational frequency and pharmacological function of a ligand, the vibrational spectrum of a molecule may shed light on the field of ligand-receptor interaction mechanisms.

Fig. 2.

Fig. 2

Radial tree of corralled intensity of molecular vibrational frequency (CIMVF) clustering using the complete linkage method. Antagonists are tagged with "t" to their chemical names as a prefix, whereas agonists are not. Agonists of histamine receptors except impromidine are located in a cluster (the part in the dotted circle).

Acknowledgments

The author would like to express sincere appreciation to Prof. C. H. Choi for the use of his cluster computer and his valuable advice. This work was supported by the 2010 Inje University research grant.

References

  • 1.Bleicher KH, Bohm HJ, Müller K, Alanine AI. Hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discov. 2003;2:369–378. doi: 10.1038/nrd1086. [DOI] [PubMed] [Google Scholar]
  • 2.Zheng CJ, Han LY, Yap CW, Ji ZL, Cao ZW, Chen YZ. Therapeutic targets: progress of their exploration and investigation of their characteristics. Pharmacol Rev. 2006;58:259–279. doi: 10.1124/pr.58.2.4. [DOI] [PubMed] [Google Scholar]
  • 3.Drews J. Drug discovery: a historical perspective. Science. 2000;287:1960–1964. doi: 10.1126/science.287.5460.1960. [DOI] [PubMed] [Google Scholar]
  • 4.Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science. 2007;318:1258–1265. doi: 10.1126/science.1150577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Chien EY, Liu W, Zhao Q, Katritch V, Han GW, Hanson MA, et al. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science. 2010;330:1091–1095. doi: 10.1126/science.1197410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Shimamura T, Shiroishi M, Weyand S, Tsujimoto H, Winter G, Katritch V, et al. Structure of the human histamine H1 receptor complex with doxepin. Nature. 2011;475:65–70. doi: 10.1038/nature10236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Medina VA, Rivera ES. Histamine receptors and cancer pharmacology. Br J Pharmacol. 2010;161:755–767. doi: 10.1111/j.1476-5381.2010.00961.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M. Histaminergic transmission in the mammalian brain. Physiol Rev. 1991;71:1–51. doi: 10.1152/physrev.1991.71.1.1. [DOI] [PubMed] [Google Scholar]
  • 9.Hill SJ. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol Rev. 1990;42:45–83. [PubMed] [Google Scholar]
  • 10.Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, et al. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev. 1997;49:253–278. [PubMed] [Google Scholar]
  • 11.Keller A, Vosshall LB. A psychophysical test of the vibration theory of olfaction. Nat Neurosci. 2004;7:337–338. doi: 10.1038/nn1215. [DOI] [PubMed] [Google Scholar]
  • 12.Takane SY, Mitchell JB. A structure-odour relationship study using EVA descriptors and hierarchical clustering. Org Biomol Chem. 2004;2:3250–3255. doi: 10.1039/B409802A. [DOI] [PubMed] [Google Scholar]
  • 13.Godden JW, Xue L, Bajorath J. Combinatorial preferences affect molecular similarity/diversity calculations using binary fingerprints and Tanimoto coefficients. J Chem Inf Comput Sci. 2000;40:163–166. doi: 10.1021/ci990316u. [DOI] [PubMed] [Google Scholar]
  • 14.Schmidt MW, Baldridge KK, Boatz JA, Elbert ST, Gordon MS, Jensen JH, et al. General atomic and molecular electronic structure system. J Comput Chem. 1993;14:1347–1363. [Google Scholar]
  • 15.Keseru GM, Makara GM. The influence of lead discovery strategies on the properties of drug candidates. Nat Rev Drug Discov. 2009;8:203–212. doi: 10.1038/nrd2796. [DOI] [PubMed] [Google Scholar]

Articles from Genomics & Informatics are provided here courtesy of BMC

RESOURCES